C-terminal variable AGES domain of Thymosin β4: The molecule's primary contribution in support of post-ischemic cardiac function and repair

Rabea Hinkel, Haydn L. Ball, J. Michael DiMaio, Santwana Shrivastava, Jeffrey E. Thatcher, Ajay N. Singh, Xiankai Sun, Gabor Faskerti, Eric N. Olson, Christian Kupatt, Ildiko Bock-Marquette

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Repairing defective cardiac cells is important towards improving heart function. Due to the frequency and severity of ischemic heart disease, management of patients featuring this type of cardiac failure receives significant interest. Previously we discovered that Thymosin β4 (TB4), a 43 amino-acid secreted actin sequestering peptide, is beneficial for myocardial cell survival and coronary re-growth after infarction in adult mammals. Considering the regenerative potential of full-length TB4 in the heart, and that minimal structural variations alter TB4's influence on actin assembly and cell movement, we investigated how various TB4 domains affect cardiac cell behavior and post-ischemic mammalian heart function.We synthesized 17 domain combinations of full-length TB4 and analyzed their impact on embryonic cardiac cells in vitro, and after cardiac infarction in vivo. We discovered the domains of TB4 affect cardiac cell behavior distinctly. We revealed TB4 specific C-terminal tetrapeptide, AGES, increases embryonic cardiac cell migration and myocyte beating in culture, and improves adult mammalian heart function following ischemia. Investigating the molecular background and mechanism we discovered systemic injection of AGES enhances early myocyte survival by activating Akt-mediated signaling mechanisms, increases coronary vessel growth and inhibits inflammation in mice and pigs. Biodistribution analyses revealed cardiomyocytes uptake AGES efficiently in vitro and in vivo projecting a potential independent clinical utilization for the tetrapeptide. Our comprehensive domain investigations also suggest, preservation and/or restoration of cardiomyocyte communication is a target of TB4 and AGES, and critical to improve post-ischemic heart function in pigs.In summary, we identified the C-terminal four amino-acid variable end of TB4 as the essential and responsible domain for the molecule's full benefits in the hypoxic heart. Additionally, we introduced AGES as a novel, systemically applicable drug candidate to aid cardiac infarction in adult mammals.

Original languageEnglish (US)
Pages (from-to)113-125
Number of pages13
JournalJournal of Molecular and Cellular Cardiology
Volume87
DOIs
StatePublished - Oct 1 2015

Fingerprint

Thymosin
Infarction
Cardiac Myocytes
Muscle Cells
Cell Movement
Actins
Mammals
Swine
Amino Acids
Disease Management
Growth
Myocardial Ischemia
Cell Survival
Coronary Vessels
Ischemia
Heart Failure
Communication
Inflammation
Peptides
Injections

Keywords

  • Connexins
  • Drug research
  • Infarct remodeling
  • Myocardial infarction
  • Thymosin beta-4

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

C-terminal variable AGES domain of Thymosin β4 : The molecule's primary contribution in support of post-ischemic cardiac function and repair. / Hinkel, Rabea; Ball, Haydn L.; DiMaio, J. Michael; Shrivastava, Santwana; Thatcher, Jeffrey E.; Singh, Ajay N.; Sun, Xiankai; Faskerti, Gabor; Olson, Eric N.; Kupatt, Christian; Bock-Marquette, Ildiko.

In: Journal of Molecular and Cellular Cardiology, Vol. 87, 01.10.2015, p. 113-125.

Research output: Contribution to journalArticle

Hinkel, Rabea ; Ball, Haydn L. ; DiMaio, J. Michael ; Shrivastava, Santwana ; Thatcher, Jeffrey E. ; Singh, Ajay N. ; Sun, Xiankai ; Faskerti, Gabor ; Olson, Eric N. ; Kupatt, Christian ; Bock-Marquette, Ildiko. / C-terminal variable AGES domain of Thymosin β4 : The molecule's primary contribution in support of post-ischemic cardiac function and repair. In: Journal of Molecular and Cellular Cardiology. 2015 ; Vol. 87. pp. 113-125.
@article{68b38172cf504e22a4801ad2e0e05876,
title = "C-terminal variable AGES domain of Thymosin β4: The molecule's primary contribution in support of post-ischemic cardiac function and repair",
abstract = "Repairing defective cardiac cells is important towards improving heart function. Due to the frequency and severity of ischemic heart disease, management of patients featuring this type of cardiac failure receives significant interest. Previously we discovered that Thymosin β4 (TB4), a 43 amino-acid secreted actin sequestering peptide, is beneficial for myocardial cell survival and coronary re-growth after infarction in adult mammals. Considering the regenerative potential of full-length TB4 in the heart, and that minimal structural variations alter TB4's influence on actin assembly and cell movement, we investigated how various TB4 domains affect cardiac cell behavior and post-ischemic mammalian heart function.We synthesized 17 domain combinations of full-length TB4 and analyzed their impact on embryonic cardiac cells in vitro, and after cardiac infarction in vivo. We discovered the domains of TB4 affect cardiac cell behavior distinctly. We revealed TB4 specific C-terminal tetrapeptide, AGES, increases embryonic cardiac cell migration and myocyte beating in culture, and improves adult mammalian heart function following ischemia. Investigating the molecular background and mechanism we discovered systemic injection of AGES enhances early myocyte survival by activating Akt-mediated signaling mechanisms, increases coronary vessel growth and inhibits inflammation in mice and pigs. Biodistribution analyses revealed cardiomyocytes uptake AGES efficiently in vitro and in vivo projecting a potential independent clinical utilization for the tetrapeptide. Our comprehensive domain investigations also suggest, preservation and/or restoration of cardiomyocyte communication is a target of TB4 and AGES, and critical to improve post-ischemic heart function in pigs.In summary, we identified the C-terminal four amino-acid variable end of TB4 as the essential and responsible domain for the molecule's full benefits in the hypoxic heart. Additionally, we introduced AGES as a novel, systemically applicable drug candidate to aid cardiac infarction in adult mammals.",
keywords = "Connexins, Drug research, Infarct remodeling, Myocardial infarction, Thymosin beta-4",
author = "Rabea Hinkel and Ball, {Haydn L.} and DiMaio, {J. Michael} and Santwana Shrivastava and Thatcher, {Jeffrey E.} and Singh, {Ajay N.} and Xiankai Sun and Gabor Faskerti and Olson, {Eric N.} and Christian Kupatt and Ildiko Bock-Marquette",
year = "2015",
month = "10",
day = "1",
doi = "10.1016/j.yjmcc.2015.07.004",
language = "English (US)",
volume = "87",
pages = "113--125",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - C-terminal variable AGES domain of Thymosin β4

T2 - The molecule's primary contribution in support of post-ischemic cardiac function and repair

AU - Hinkel, Rabea

AU - Ball, Haydn L.

AU - DiMaio, J. Michael

AU - Shrivastava, Santwana

AU - Thatcher, Jeffrey E.

AU - Singh, Ajay N.

AU - Sun, Xiankai

AU - Faskerti, Gabor

AU - Olson, Eric N.

AU - Kupatt, Christian

AU - Bock-Marquette, Ildiko

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Repairing defective cardiac cells is important towards improving heart function. Due to the frequency and severity of ischemic heart disease, management of patients featuring this type of cardiac failure receives significant interest. Previously we discovered that Thymosin β4 (TB4), a 43 amino-acid secreted actin sequestering peptide, is beneficial for myocardial cell survival and coronary re-growth after infarction in adult mammals. Considering the regenerative potential of full-length TB4 in the heart, and that minimal structural variations alter TB4's influence on actin assembly and cell movement, we investigated how various TB4 domains affect cardiac cell behavior and post-ischemic mammalian heart function.We synthesized 17 domain combinations of full-length TB4 and analyzed their impact on embryonic cardiac cells in vitro, and after cardiac infarction in vivo. We discovered the domains of TB4 affect cardiac cell behavior distinctly. We revealed TB4 specific C-terminal tetrapeptide, AGES, increases embryonic cardiac cell migration and myocyte beating in culture, and improves adult mammalian heart function following ischemia. Investigating the molecular background and mechanism we discovered systemic injection of AGES enhances early myocyte survival by activating Akt-mediated signaling mechanisms, increases coronary vessel growth and inhibits inflammation in mice and pigs. Biodistribution analyses revealed cardiomyocytes uptake AGES efficiently in vitro and in vivo projecting a potential independent clinical utilization for the tetrapeptide. Our comprehensive domain investigations also suggest, preservation and/or restoration of cardiomyocyte communication is a target of TB4 and AGES, and critical to improve post-ischemic heart function in pigs.In summary, we identified the C-terminal four amino-acid variable end of TB4 as the essential and responsible domain for the molecule's full benefits in the hypoxic heart. Additionally, we introduced AGES as a novel, systemically applicable drug candidate to aid cardiac infarction in adult mammals.

AB - Repairing defective cardiac cells is important towards improving heart function. Due to the frequency and severity of ischemic heart disease, management of patients featuring this type of cardiac failure receives significant interest. Previously we discovered that Thymosin β4 (TB4), a 43 amino-acid secreted actin sequestering peptide, is beneficial for myocardial cell survival and coronary re-growth after infarction in adult mammals. Considering the regenerative potential of full-length TB4 in the heart, and that minimal structural variations alter TB4's influence on actin assembly and cell movement, we investigated how various TB4 domains affect cardiac cell behavior and post-ischemic mammalian heart function.We synthesized 17 domain combinations of full-length TB4 and analyzed their impact on embryonic cardiac cells in vitro, and after cardiac infarction in vivo. We discovered the domains of TB4 affect cardiac cell behavior distinctly. We revealed TB4 specific C-terminal tetrapeptide, AGES, increases embryonic cardiac cell migration and myocyte beating in culture, and improves adult mammalian heart function following ischemia. Investigating the molecular background and mechanism we discovered systemic injection of AGES enhances early myocyte survival by activating Akt-mediated signaling mechanisms, increases coronary vessel growth and inhibits inflammation in mice and pigs. Biodistribution analyses revealed cardiomyocytes uptake AGES efficiently in vitro and in vivo projecting a potential independent clinical utilization for the tetrapeptide. Our comprehensive domain investigations also suggest, preservation and/or restoration of cardiomyocyte communication is a target of TB4 and AGES, and critical to improve post-ischemic heart function in pigs.In summary, we identified the C-terminal four amino-acid variable end of TB4 as the essential and responsible domain for the molecule's full benefits in the hypoxic heart. Additionally, we introduced AGES as a novel, systemically applicable drug candidate to aid cardiac infarction in adult mammals.

KW - Connexins

KW - Drug research

KW - Infarct remodeling

KW - Myocardial infarction

KW - Thymosin beta-4

UR - http://www.scopus.com/inward/record.url?scp=84939780793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939780793&partnerID=8YFLogxK

U2 - 10.1016/j.yjmcc.2015.07.004

DO - 10.1016/j.yjmcc.2015.07.004

M3 - Article

C2 - 26255251

AN - SCOPUS:84939780793

VL - 87

SP - 113

EP - 125

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

ER -